TY - JOUR
T1 - Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI)
T2 - an extension of the STROBE statement for neonatal infection research
AU - Fitchett, Elizabeth J.A.
AU - Seale, Anna C.
AU - Vergnano, Stefania
AU - Sharland, Michael
AU - Heath, Paul T.
AU - Saha, Samir K.
AU - Agarwal, Ramesh
AU - Ayede, Adejumoke I.
AU - Bhutta, Zulfiqar A.
AU - Black, Robert
AU - Bojang, Kalifa
AU - Campbell, Harry
AU - Cousens, Simon
AU - Darmstadt, Gary L.
AU - Madhi, Shabir A.
AU - Meulen, Ajoke Sobanjo ter
AU - Modi, Neena
AU - Patterson, Janna
AU - Qazi, Shamim
AU - Schrag, Stephanie J.
AU - Stoll, Barbara J.
AU - Wall, Stephen N.
AU - Wammanda, Robinson D.
AU - Lawn, Joy E.
N1 - Funding Information:
SKS has received a grant from the Bill & Melinda Gates Foundation to run a multicountry study on neonatal infection in south Asia. SAM reports grants from the Bill & Melinda Gates Foundation, grants and personal fees from GSK, grants and personal fees from Pfizer, personal fees from MedImmune, and personal fees from Sanofi Pasteur, outside the submitted work. AS-tM and JP are salaried employees of the Bill & Melinda Gates Foundation. AS-tM was previously a salaried employee for Novartis Vaccines Research and Development (2012–13). NM reports membership of the steering groups of the UK Infection in Critical Care Quality Improvement Programme, the Royal College of Paediatrics and Child Health National Neonatal Audit Programme, the UK Neonatal Data Analysis Unit, the International Neonatal Benchmarking and Evaluation Programme (eNewborn), and the International Network for Evaluation of Outcomes in neonates (iNeo), all of which are involved in population-based reporting of neonatal infections. All other authors declare no competing interests.
Funding Information:
No specific funding was received for this work. Travel fellowships for experts attending the consensus meeting were provided by the Wellcome Trust, WHO, and the Bill & Melinda Gates Foundation through a grant to the Johns Hopkins Bloomberg School of Public Health. We thank the Royal Society of Medicine (Global Health Section) for hosting the expert consensus meeting and the members of the SPRING Group.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Neonatal infections are estimated to account for a quarter of the 2·8 million annual neonatal deaths, as well as approximately 3% of all disability-adjusted life-years. Despite this burden, few data are available on incidence, aetiology, and outcomes, particularly regarding impairment. We aimed to develop guidelines for improved scientific reporting of observational neonatal infection studies, to increase comparability and to strengthen research in this area. This checklist, Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE- NI), is an extension of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement. STROBE-NI was developed following systematic reviews of published literature (1996–2015), compilation of more than 130 potential reporting recommendations, and circulation of a survey to relevant professionals worldwide, eliciting responses from 147 professionals from 37 countries. An international consensus meeting of 18 participants (with expertise in infectious diseases, neonatology, microbiology, epidemiology, and statistics) identified priority recommendations for reporting, additional to the STROBE statement. Implementation of these STROBE-NI recommendations, and linked checklist, aims to improve scientific reporting of neonatal infection studies, increasing data utility and allowing meta-analyses and pathogen-specific burden estimates to inform global policy and new interventions, including maternal vaccines.
AB - Neonatal infections are estimated to account for a quarter of the 2·8 million annual neonatal deaths, as well as approximately 3% of all disability-adjusted life-years. Despite this burden, few data are available on incidence, aetiology, and outcomes, particularly regarding impairment. We aimed to develop guidelines for improved scientific reporting of observational neonatal infection studies, to increase comparability and to strengthen research in this area. This checklist, Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE- NI), is an extension of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement. STROBE-NI was developed following systematic reviews of published literature (1996–2015), compilation of more than 130 potential reporting recommendations, and circulation of a survey to relevant professionals worldwide, eliciting responses from 147 professionals from 37 countries. An international consensus meeting of 18 participants (with expertise in infectious diseases, neonatology, microbiology, epidemiology, and statistics) identified priority recommendations for reporting, additional to the STROBE statement. Implementation of these STROBE-NI recommendations, and linked checklist, aims to improve scientific reporting of neonatal infection studies, increasing data utility and allowing meta-analyses and pathogen-specific burden estimates to inform global policy and new interventions, including maternal vaccines.
UR - http://www.scopus.com/inward/record.url?scp=84990059410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990059410&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(16)30082-2
DO - 10.1016/S1473-3099(16)30082-2
M3 - Review article
C2 - 27633910
AN - SCOPUS:84990059410
SN - 1473-3099
VL - 16
SP - e202-e213
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 10
ER -